-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KGh/59W6h+PkRElSUpeUL/2Edt8O4pI0JXNamc6wlyQSQEd5s3Ekv0wnARy+YceT zR/qf7FOA3prdA98EEbuMw== 0001362310-09-004747.txt : 20090402 0001362310-09-004747.hdr.sgml : 20090402 20090401192100 ACCESSION NUMBER: 0001362310-09-004747 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090401 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20090402 DATE AS OF CHANGE: 20090401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30489 FILM NUMBER: 09724902 BUSINESS ADDRESS: STREET 1: 6400 SOUTH FIDDLER STREET 2: SUITE 1750 CITY: ENGLEWOOD STATE: CO ZIP: 80111 BUSINESS PHONE: 720-488-1711 MAIL ADDRESS: STREET 1: 6400 SOUTH FIDDLER STREET 2: SUITE 1750 CITY: ENGLEWOOD STATE: CO ZIP: 80111 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 8-K 1 c83452e8vk.htm FORM 8-K Form 8-K
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 1, 2009 (March 27, 2009)

Lifevantage Corporation
 (Exact name of registrant as specified in its charter)
         
Colorado   000-30489   90-0224471
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
11545 W. Bernardo Court, Suite 301, San Diego, California
  92127
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (858) 312-8000
 
 
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1

 

Item 5.02  
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Amendment to 2007 Long Term Incentive Plan

On March 27, 2009, the Board of Directors of Lifevantage Corporation (the “Company”) approved an amendment to the Company’s 2007 Long Term Incentive Plan (the “Plan”) in order to increase the number of shares reserved for issuance under the Plan to 10,000,000 shares of common stock. The Company will submit the amendment to the Plan to the shareholders of the Company for approval at the next annual meeting of shareholders.

Option Grants

On March 27, 2009, the Board of Directors of the Company approved option grants to the Company’s Chief Executive Officer and Chief Financial Officer. David Brown, the Company’s Chief Executive Officer, received an incentive stock option grant to purchase 300,000 shares of common stock of the Company. Brad Amman, the Company’s Chief Financial Officer, received an incentive stock option grant to purchase 120,000 shares of common stock of the Company (the “Options”). Each of the Options has an exercise price of $0.70, which was the closing price of the Company’s common stock as quoted on the OTC Bulletin Board on the date of grant. The Options will vest in full on the date that is twelve months following the date of grant and are subject to the terms of the Plan.

 

2

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: April 1, 2009

LIFEVANTAGE CORPORATION

By: /s/ Bradford K. Amman
Bradford K. Amman
Chief Financial Officer

 

3

-----END PRIVACY-ENHANCED MESSAGE-----